Dr. Aram Francis Hezel, MD

Dr. Hezel practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Hezel's NPI, 1144202607, was assigned on November 18, 2005. Dr. Hezel graduated from Jacobs School of Medicine and Biomedical Sciences in 2000. Dr. Hezel holds New York license 253233.

Dr. Hezel's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Hezel's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dr. Hezel is also affiliated with Highland Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Hezel to 2 more hospitals, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hezel practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hezel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hezel is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Hezel's licenses on file in 2 states: New York and Massachusetts.

Dmand AI lists colorectal cancer, neutropenia and prostate cancer among the conditions Dr. Hezel treats.

CMS data shows 189 Medicare services from Dr. Hezel across 3 procedure codes in 2024, for 60 Medicare patients. Medicare paid $16,683 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Hezel in 2024. The largest group is 65 to 74, with 32 patients. 72% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 2.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hezel's median patient age at 69, with 50% women.

In 2024, Dr. Hezel wrote 75 Medicare Part D claims for 29 patients. 88% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $252 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

Dr. Hezel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hezel as offering telehealth.

Dmand AI links 93 papers to Dr. Hezel, published from 2006 to 2025. 2014 was the busiest year, with 7. The most frequent topics are Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal and Disease Models, Animal. Dr. Hezel has published most often in Cancer Res. Dr. Hezel's most frequent co-authors are Albert C. Koong, MD, PhD, David C. Linehan, MD and Daniel Tandel Chang, MD.

Dmand AI links Dr. Hezel to 5 clinical trials, 4 of them phase 2 studies. Conditions studied include Carcinoma, Pancreatic Ductal, Gallbladder Neoplasms and Rectal Diseases.

CMS Open Payments shows 104 general payments to Dr. Hezel from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Merck Sharp & Dohme Corporation paid the most, $66,095. It also lists 1 research payment totaling $1,500 in 2016.

Dmand AI lists 1 award for Dr. Hezel, most recently CMS Stage 1 EHR in 2013.

Dr. Hezel graduated from Jacobs School of Medicine and Biomedical Sciences in 2000. Dr. Hezel is a member of ASCO.

Dr. Hezel is in network with 12 carriers, including Aetna, MVP Health Care and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.